NF-κB-mediated HER2 overexpression in radiation-adaptive resistance

Ning Cao, Shiyong Li, Zhaoqing Wang, Kazi Mokim Ahmed, Michael E. Degnan, Ming Fan, Joseph R. Dynlach, Jian-Jian Li

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

The molecular mechanisms governing acquired tumor resistance during radiotherapy remain to be elucidated. In breast cancer patients, overexpression of HER2 (human epidermal growth factor receptor 2) is correlated with aggressive tumor growth and increased recurrence. In the present study, we demonstrate that HER2 expression can be induced by radiation in breast cancer cells with a low basal level of HER2. Furthermore, HER2-postive tumors occur at a much higher frequency in recurrent invasive breast cancer (59%) compared to the primary tumors (41%). Interestingly, NF-KBis required for radiation-induced HER2 transactivation. HER2 was found to be co-activated with basal and radiation-induced NF-κB activity in radioresistant but not radiosensitive breast cancer cell lines after long-term radiation exposure, indicating that NF-κB-mediated HER2 overexpression is involved in radiation-induced repopulation in heterogeneous tumors. Finally, we found that inhibition of HER2 resensitizes the resistant cell lines to radiation. Since HER2 is shown to activate NF-κB, our data suggest a loop-like HER2-NF-κB-HER2 pathway in radiation-induced adaptive resistance in breast cancer cells.

Original languageEnglish (US)
Pages (from-to)9-21
Number of pages13
JournalRadiation Research
Volume171
Issue number1
DOIs
StatePublished - Jan 2009
Externally publishedYes

Fingerprint

Radiation
radiation
breast
tumors
cancer
Breast Neoplasms
Neoplasms
cultured cells
human ERBB2 protein
Cell Line
radiation dosage
Transcriptional Activation
Radiotherapy
radiation therapy
Recurrence
Growth

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Biophysics
  • Radiation

Cite this

Cao, N., Li, S., Wang, Z., Ahmed, K. M., Degnan, M. E., Fan, M., ... Li, J-J. (2009). NF-κB-mediated HER2 overexpression in radiation-adaptive resistance. Radiation Research, 171(1), 9-21. https://doi.org/10.1667/RR1472.1

NF-κB-mediated HER2 overexpression in radiation-adaptive resistance. / Cao, Ning; Li, Shiyong; Wang, Zhaoqing; Ahmed, Kazi Mokim; Degnan, Michael E.; Fan, Ming; Dynlach, Joseph R.; Li, Jian-Jian.

In: Radiation Research, Vol. 171, No. 1, 01.2009, p. 9-21.

Research output: Contribution to journalArticle

Cao, N, Li, S, Wang, Z, Ahmed, KM, Degnan, ME, Fan, M, Dynlach, JR & Li, J-J 2009, 'NF-κB-mediated HER2 overexpression in radiation-adaptive resistance', Radiation Research, vol. 171, no. 1, pp. 9-21. https://doi.org/10.1667/RR1472.1
Cao N, Li S, Wang Z, Ahmed KM, Degnan ME, Fan M et al. NF-κB-mediated HER2 overexpression in radiation-adaptive resistance. Radiation Research. 2009 Jan;171(1):9-21. https://doi.org/10.1667/RR1472.1
Cao, Ning ; Li, Shiyong ; Wang, Zhaoqing ; Ahmed, Kazi Mokim ; Degnan, Michael E. ; Fan, Ming ; Dynlach, Joseph R. ; Li, Jian-Jian. / NF-κB-mediated HER2 overexpression in radiation-adaptive resistance. In: Radiation Research. 2009 ; Vol. 171, No. 1. pp. 9-21.
@article{d73999702c7e46508f01488d73af7c74,
title = "NF-κB-mediated HER2 overexpression in radiation-adaptive resistance",
abstract = "The molecular mechanisms governing acquired tumor resistance during radiotherapy remain to be elucidated. In breast cancer patients, overexpression of HER2 (human epidermal growth factor receptor 2) is correlated with aggressive tumor growth and increased recurrence. In the present study, we demonstrate that HER2 expression can be induced by radiation in breast cancer cells with a low basal level of HER2. Furthermore, HER2-postive tumors occur at a much higher frequency in recurrent invasive breast cancer (59{\%}) compared to the primary tumors (41{\%}). Interestingly, NF-KBis required for radiation-induced HER2 transactivation. HER2 was found to be co-activated with basal and radiation-induced NF-κB activity in radioresistant but not radiosensitive breast cancer cell lines after long-term radiation exposure, indicating that NF-κB-mediated HER2 overexpression is involved in radiation-induced repopulation in heterogeneous tumors. Finally, we found that inhibition of HER2 resensitizes the resistant cell lines to radiation. Since HER2 is shown to activate NF-κB, our data suggest a loop-like HER2-NF-κB-HER2 pathway in radiation-induced adaptive resistance in breast cancer cells.",
author = "Ning Cao and Shiyong Li and Zhaoqing Wang and Ahmed, {Kazi Mokim} and Degnan, {Michael E.} and Ming Fan and Dynlach, {Joseph R.} and Jian-Jian Li",
year = "2009",
month = "1",
doi = "10.1667/RR1472.1",
language = "English (US)",
volume = "171",
pages = "9--21",
journal = "Radiation Research",
issn = "0033-7587",
publisher = "Radiation Research Society",
number = "1",

}

TY - JOUR

T1 - NF-κB-mediated HER2 overexpression in radiation-adaptive resistance

AU - Cao, Ning

AU - Li, Shiyong

AU - Wang, Zhaoqing

AU - Ahmed, Kazi Mokim

AU - Degnan, Michael E.

AU - Fan, Ming

AU - Dynlach, Joseph R.

AU - Li, Jian-Jian

PY - 2009/1

Y1 - 2009/1

N2 - The molecular mechanisms governing acquired tumor resistance during radiotherapy remain to be elucidated. In breast cancer patients, overexpression of HER2 (human epidermal growth factor receptor 2) is correlated with aggressive tumor growth and increased recurrence. In the present study, we demonstrate that HER2 expression can be induced by radiation in breast cancer cells with a low basal level of HER2. Furthermore, HER2-postive tumors occur at a much higher frequency in recurrent invasive breast cancer (59%) compared to the primary tumors (41%). Interestingly, NF-KBis required for radiation-induced HER2 transactivation. HER2 was found to be co-activated with basal and radiation-induced NF-κB activity in radioresistant but not radiosensitive breast cancer cell lines after long-term radiation exposure, indicating that NF-κB-mediated HER2 overexpression is involved in radiation-induced repopulation in heterogeneous tumors. Finally, we found that inhibition of HER2 resensitizes the resistant cell lines to radiation. Since HER2 is shown to activate NF-κB, our data suggest a loop-like HER2-NF-κB-HER2 pathway in radiation-induced adaptive resistance in breast cancer cells.

AB - The molecular mechanisms governing acquired tumor resistance during radiotherapy remain to be elucidated. In breast cancer patients, overexpression of HER2 (human epidermal growth factor receptor 2) is correlated with aggressive tumor growth and increased recurrence. In the present study, we demonstrate that HER2 expression can be induced by radiation in breast cancer cells with a low basal level of HER2. Furthermore, HER2-postive tumors occur at a much higher frequency in recurrent invasive breast cancer (59%) compared to the primary tumors (41%). Interestingly, NF-KBis required for radiation-induced HER2 transactivation. HER2 was found to be co-activated with basal and radiation-induced NF-κB activity in radioresistant but not radiosensitive breast cancer cell lines after long-term radiation exposure, indicating that NF-κB-mediated HER2 overexpression is involved in radiation-induced repopulation in heterogeneous tumors. Finally, we found that inhibition of HER2 resensitizes the resistant cell lines to radiation. Since HER2 is shown to activate NF-κB, our data suggest a loop-like HER2-NF-κB-HER2 pathway in radiation-induced adaptive resistance in breast cancer cells.

UR - http://www.scopus.com/inward/record.url?scp=58349107292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58349107292&partnerID=8YFLogxK

U2 - 10.1667/RR1472.1

DO - 10.1667/RR1472.1

M3 - Article

VL - 171

SP - 9

EP - 21

JO - Radiation Research

JF - Radiation Research

SN - 0033-7587

IS - 1

ER -